Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Seven Biotech Drugs to Watch in the Second Quarter
Seven Biotech Drugs to Watch in the Second Quarter
Seven Biotech Drugs to Watch in the Second Quarter
Submitted by
admin
on April 13, 2010 - 10:35am
Source:
BNET Pharma
News Tags:
Acorda Therapeutics
AMPYRA
Cell Therapeutics
pixantrone
Pixuvri
Dendreon
Provenge
InterMune
Esbriet
Pozen
Vimovo
XenoPort
Horizant
Astellas
OSI Pharmaceuticals
Ironwood
Headline:
Seven Biotech Drugs to Watch in the Second Quarter
Do Not Allow Advertisers to Use My Personal information